Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Tools & Techniques

Tools & Techniques Immunology

Inside Intestinal Disease

| Sheena Cruickshank

Gut mucus microbiota could lead to earlier diagnosis, or even prediction, of inflammatory bowel disease.

Tools & Techniques Cell & gene therapy

Babies’ Breath

| Jegen Kandasamy

Research reveals a potential noninvasive predictor of bronchopulmonary dysplasia risk in preterm infants

Tools & Techniques Neuroscience

(B)rainbow

A colorful mouse brain provides insight into autism spectrum disorder.

Tools & Techniques Cancer

Rush at Your Peril

| Eleftherios P. Diamandis

False discoveries have plagued biomarker research for years: don't trust everything you read.

Tools & Techniques Analytical science

The Hunt for an HD Blood Test

| Roisin McGuigan

Do we finally have an effective blood biomarker for studying progression of Huntington’s disease?

Tools & Techniques Immunology

The ABCs of Autoimmunity

| Michael Schubert

A unique type of B cell appears to play a role in the development of autoimmune disorders.

Tools & Techniques Analytical science

The Importance of Chiral Metabolomics

Could chiral amino acids function as biomarkers for kidney disease?

Tools & Techniques Cancer

CEA: Overlooked and Underused

| Roisin McGuigan

Could an existing blood test improve treatment choices – and outcomes – for some colon cancer patients?

Tools & Techniques Cancer

Getting Smart with Clinical Trials

| Joy Yucaitis

Liquid biopsy technology could help boost clinical trial success.

Tools & Techniques Cell & gene therapy

Stem Cell Stepping Stones

| Roisin McGuigan

A new treatment for STAT1 mutations has a disappointingly low success rate – but shows potential.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register